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Abstract 
This thesis examines methodological and clinical aspects of hair cortisol analysis.  
The methodological study examines the role of sweat as a contributor to  hair 
cortisol concentrations.  Hair cortisol analysis is an effective measure of chronic 
stress.  Cortisol is assumed to enter the hair via blood, sebum, and sweat, however 
the extent to which sweat contributes to hair cortisol content was unknown.   This 
study concluded that human sweat contains cortisol that likely contributes to hair 
cortisol content. Subjects with prolonged sweating at the time of hair collection may 
have increased hair cortisol concentrations that cannot be decreased with 
conventional laboratory washing procedures.  Clinically, hair cortisol analysis is 
explored as a tool to determine if obstructive sleep apnea (OSA) is associated with 
increased stress.  OSA is a common sleep disorder with serious cardiovascular and 
metabolic co-morbidities that may be mediated by increased cortisol secretion. 
Recent studies have focused on the ability of continuous positive airway pressure 
(CPAP) to reduce cortisol secretion in OSA patients, but the results have been 
mixed and only point measures of cortisol measurement have been used.  Hair 
cortisol analysis presents a means of non-invasively and retrospectively examining 
cortisol production in these patients. This study examined whether hair cortisol 
concentrations are increased in OSA patients.  Further, the effect of CPAP on hair 
cortisol concentrations was examined.  It was concluded that cortisol secretion may 
be up-regulated in severe cases of OSA.  The psychological stress of OSA may be 
reduced with CPAP, however physiological stress may remain unchanged after 3 
months of treatment. 
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Chapter 1: Introduction 
Parts of this chapter have been published: 
Russell E, Koren G, Rieder M, Van Uum S. Hair cortisol as a biological marker of 
chronic stress: Current status, future directions and unanswered questions. 
Psychoneuroendocrinology 2012. 37:589-601.  
1.1 The Role of Stress in Health 
The term stress refers to the body’s nonspecific adaptive response to try to 
adapt to a perturbation.  The source of the stress, the stressor, may be actual or 
perceived, and can be psychological or physiological (SELYE ,1950). The sum of 
physiological effort to compensate for the perturbations caused by a stressor is 
defined as the allostatic load (McEwen ,1998).  Allostatic load can be quantified 
through measurement of physical changes such as blood pressure, heart rate, 
waist-hip-ratio, and body fat percentage, or through biochemical concentrations 
of various substances, including cortisol, catecholamines, high-density lipoprotein 
(HDL), total cholesterol:HDL ratio, triglycerides, glycosylated haemoglobin, 
glucose levels, C-reactive protein, fibrinogen, D-dimer, and tumour-necrosis-
factor-alpha (Bellingrath et al. 2008).   Initially, the physiologic changes induced 
by the stress response serve an adaptive role as the body attempts to maintain 
homeostasis in spite of the stressor, but a sustained increase in allostatic load is 
associated with a host of deleterious consequences.  These may include the 
development or exacerbation of mental health disorders (Kessler et al. 
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1985;Brady and Sinha ,2005;Kim et al. 2007;Lee et al. 2010) hypertension (Esler 
et al. 2008), an increased risk for cardiovascular disease (Appels et al. 
2000b;Dimsdale ,2008a;Appels ,1990;Dimsdale ,2008b;Appels et al. 2000a), 
obesity (Vicennati et al. 2009), type 2 diabetes (Pouwer et al. 2010), 
exacerbation of chronic obstructive pulmonary disease (Andenaes et al. 2004)  or 
asthma (Sandberg et al. 2004), exacerbation of skin conditions such as psoriasis 
(Malhotra and Mehta ,2008), an increased risk of ulcerative colitis (Mawdsley et 
al. 2006), reduced fertility (Ebbesen et al. 2009) and poor pregnancy outcome 
(Latendresse, 2009). 
A recent study by the American Psychological Association sought to 
quantify the extent to which subjective stress is present in North America.  The 
authors interviewed 1,134 adults aged 18 and up, and 1,136 children between 
the ages of 8 and 17 from 8 cities across the continental United States.  The 
study included both interviews and self-reported stress (using a Likert grading 
scale), and found that the majority of Americans have moderate to high levels of 
stress.  The three most commonly cited sources of stress were money, work, and 
economy-related. Children were more likely to cite money as a significant source 
of stress.  Perhaps most concerning is that almost half (44%) of the participants 
reported that their stress level had increased over the past 5 years (Anderson et 
al. 2011).  In light of the above-mentioned significant sequelae associated with 
stress, this study underscores the need of finding an objective means of 
quantifying the degree of chronic stress.  Such a biomarker would potentially help 
facilitate earlier detection, could help identify individuals most at risk for 
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deleterious health outcomes, and hopefully help gauge effective methods to 
mitigate stress. 
1.2 Lack of a Marker for Chronic Stress 
 Biomarkers of acute stress have been well established and primarily 
assess catecholamine release.  Goldstein’s 1995 paper provides a thorough 
review of the way in which sympathetic responses can be quantified during acute 
stress (Goldstein ,1995).  In contrast, finding a “gold standard” biomarker for 
chronic stress has proved challenging given its complex etiology and the highly 
individual manifestations.   
Glucocorticoids are commonly used as biomarkers of stress.  In humans, 
non-human primates and many larger mammals cortisol is the most common 
glucocorticoid, while in other vertebrates including rodents, corticosterone is the 
primary stress hormone. As there are only very few studies on corticosterone in 
hair, cortisol will be focused on as the primary biomarker of stress.  
During times when an organism undergoes physiologic duress, cortisol 
acts to mobilize energy stores and modulate the immune system.  Cortisol is a 
steroid hormone produced by the cortices of the adrenal glands in response to 
stress (be it physiological or psychological). The signal for cortisol production 
arises in the hypothalamus that releases corticotropin releasing hormone (CRH) 
onto the anterior pituitary, which in turn releases adrenocorticotropic hormone 
(ACTH) into circulation to act upon the adrenal glands (Miller et al., 2007).  Once 
released, 90% of cortisol circulates in the blood in an inactive protein bound 
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fraction, and the remaining 10% of free cortisol is physiologically active (Lacroix 
et al., 2001). This system is subject to negative feedback; when sufficiently high, 
cortisol levels act to inhibit the system both at the level of the anterior pituitary 
and the hypothalamus (Henley et al., 2005).   
Cortisol is a derivative of a sequence of biochemical reactions that modify 
cholesterol.  Cortisol is converted into its inactivate metabolite, cortisone, via 11-
beta hydroxysteroid dehydrogenase 2 (11β-HSD2).  Cortisone can then be 
conjugated in the liver, making it soluble and capable of excretion via the 
kidneys.  Cortisol has a mean half-life of 66 minutes (Weitzman et al., 1971).  It 
should be noted that 11-beta hydroxysteroid dehydrogenase 1 (11β-HSD1) 
opposes the action of 11β-HSD2, and therefore a significant portion of cortisone 
produced is converted back to cortisol (Kacsoh, 2000). The Michaelis-Menten 
constant of 11β-HSD1 is in the µM range, whereas it is in the nM range for 11β-
HSD2 (Hammer & Stewart, 2006).  Thus, 11β-HSD2 has an approximately 3-fold 
greater binding affinity for cortisol compared to that of 11β-HSD1 for cortisone. 
Despite its well-recognized role in stress in both animals and humans, the 
ability of cortisol to reflect stress levels over long periods of time has been 
limited.  This is largely due to the nature of the traditional matrices in which 
cortisol has been sampled. To date, the majority of studies have investigated 
cortisol responses using samples of serum, saliva, or urine. The most commonly 
used assays to detect cortisol in these samples are radioimmunoassays (RIAs), 
liquid chromatography-mass spectrometry (LC-MS/MS) and enzyme-linked 
immunosorbent assays (ELISA) (Gatti et al. 2009).   
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Both saliva and serum samples provide a measurement of the cortisol 
concentration at a single point in time.  They can therefore be used to test acute 
changes, but are subject to major physiological daily fluctuations, making the 
assessment of overall long-term systemic cortisol exposure difficult.  In healthy 
individuals, plasma cortisol levels peak in the early morning, and gradually 
decrease thereafter.  Hence, a single measurement cannot reflect the integral of 
systemic exposure.  To help overcome this challenge, most contemporary 
studies obtain multiple salivary samples from the time of waking until sleep, but 
this is experimentally complex, the compliance of individual participants with the 
sampling schedule may vary (Yehuda et al. 2004), and this methodology is 
difficult to apply to larger populations.  In addition, measuring cortisol in serum 
samples assesses total serum cortisol that includes both protein-bound and 
bioactive (free) cortisol. Consequently, total serum cortisol is affected by changes 
in levels of cortisol-binding globulin (e.g. by birth control pills or pregnancy) that 
can result in increases in total cortisol concentration measured, even though 
there is no increase in stress or free cortisol concentrations.  In addition, the act 
of obtaining a sample via venipuncture could by itself be a source of stress and 
increase cortisol (Vining et al. 1983a).  Salivary cortisol concentrations correlate 
well with serum concentrations (Vining et al. 1983a;Aardal and Holm 
,1995a;Aardal and Holm ,1995b;Vining et al. 1983b). The reference ranges of 
normal serum cortisol concentrations are considered 200-800 nmol/L at 0800h 
and <300 nmol/L at 2200h (Aardal & Holm, 1995).  In contrast to serum cortisol, 
salivary cortisol reflects free (unbound) cortisol and is collected by a less-invasive 
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method.  However, salivary cortisol concentrations still fluctuate significantly 
throughout the course of the day.  The reference ranges of salivary cortisol 
concentrations are considered to be 3.5-27 nmol/L at 0800h and <6 nmol/L at 
2200h (Aardal & Holm, 1995).  A similar strategy is employed when urine is used; 
24-hour urine collections provide an integral of the free cortisol concentrations 
through the day, thus overcoming the issue of its diurnal rhythm (Burch, 1982).  
However, the collection is labor intensive for participants, and cannot be used in 
cases of chronic renal failure or dialysis.   
1.3 Hair Cortisol Analysis 
1.3.1 Development 
 Hair analysis has been used for decades to monitor exposure to 
exogenous compounds, with particular emphasis on detecting drugs of abuse 
(Gaillard et al. 1999).  Because head hair grows at an average of 1cm/month, 
assessment of drugs in hair can reflect changes in drug exposure over time 
(Wennig, 2000). More recently there has been a growing interest in quantifying 
endogenously produced compounds such as cortisol in hair (Gow et al. 2010).  
 One of the earliest studies examining whether cortisol could be detected in 
hair was performed by Koren et al. using hair from wild hyraxes (small 
herbivorous mammals) (Koren et al. 2002). In this study, the hyraxes were briefly 
captured so that 7 to 20mg of hair could be plucked.  Cortisol was then extracted 
from the hair with methanol, followed by analysis on a modified salivary ELISA.  
Cortisol was found in detectable ranges in the hair, and a significant positive 
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correlation was found between hair cortisol concentration and social ranking of 
the hyraxes.  A follow-up study to this used hair cortisol analysis to support the 
‘stress of dominance’ hypothesis.  In the most dominant group of hyraxes, higher 
hair cortisol concentrations were predictive of greater social dominance (Koren et 
al. 2008). 
 Sauvé and colleagues were the first to use an ELISA protocol similar to 
the one used by Koren et al. in 39 non-obese human subjects (Sauve et al. 
2007).  Hair cortisol concentrations were not normally distributed, but after log 
transformation a reference range of 1.7-153.2pg/mg was established, with a 
median concentration of 46.1pg/mg.  The hair cortisol concentrations obtained 
were compared against those obtained from saliva, serum, and 24 hour urine 
collections.  A positive correlation was observed between cortisol concentrations 
in hair and in 24 hour urine (r=0.333, P<0.04), but no significant correlation was 
found when comparing cortisol in hair with salivary or serum cortisol.  The 
authors postulated that this lack of correlation was due to the differences in time 
period assessed by the various matrices: saliva and serum provide information 
on brief point measures, whereas the total 24 hour urine collection provided an 
integral of production more close to the integral of production that hair analysis 
captured.  Additionally, this study reported that sampling from the vertex posterior 
region of the scalp proved optimal because it had the lowest intra-individual 
coefficient of variation for cortisol concentration. In rhesus macques, in contrast, 
there was found a significant correlation between the cortisol concentration in 
saliva and that in hair (r=0.797, P<0.001)(Davenport et al. 2006).  Bennett et al. 
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measured hair cortisol in dogs, and found that it was significantly correlated with 
cortisol in saliva (r=0.48; P<0.001) (Bennett and Hayssen ,2010). 
Cirimele and colleagues were the first to examine whether glucocorticoids 
could be detected in human hair (Cirimele et al. 2000).  Hair samples were taken 
from a deceased man who had been receiving prednisone for sarcoidosis, 
patients receiving prednisone after kidney transplantation, and patients receiving 
beclomethazone for asthma.  The glucocorticoids were extracted with incubation 
in a Sorenson buffer.  Using high performance liquid chromatography-ion spray 
mass spectrometry, a total of ten glucocorticoids, including cortisol and cortisone, 
were detected in hair.  A follow-up study by Raul et al. showed that in hair 
samples of 44 subjects a mean hair cortisol concentration of 18pg/mg, ranging 
from 5-91pg/mg, could be detected (Raul et al. 2004).  Cortisone was also 
quantified in this study, and, interestingly, cortisone concentrations in hair were 
higher than cortisol concentrations, unlike plasma in which concentrations of 
cortisol are significantly higher than of cortisone.  It was postulated that this might 
be due to increased activity of 11β-hydroxysteroid dehydrogenase type 2 (the 
enzyme responsible for converting cortisol to inactive cortisone) in the hair bulb 
(Tiganescu et al., 2011). 
Of note, in addition to glucocorticoids, a variety of other steroid hormones 
including estradiol, progesterone, and testosterone are known to incorporate into 
hair (Yang et al., 1999). 
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1.3.2 Advantages 
There are various advantages to using cortisol in hair as a biomarker of 
chronic stress.  Hair has a fairly predictable growth rate of approximately 1cm per 
month. Therefore the most proximal 1cm segment to the scalp approximates the 
last month’s cortisol production, the second most proximal 1cm segment 
approximates the production during the month before that and so on (Wennig 
,2000).  This phenomenon enables researchers to retrospectively examine 
cortisol production at the times when a stressor was most salient, without 
needing to take a sample right at that time.  Alternatively, it can provide a 
baseline cortisol assessment for a time period during which the stress had not 
yet occurred. This was demonstrated in a study in rhesus macaques in which 
hair samples for cortisol were obtained both at baseline and after a major 
stressful event (relocation to a new habitat) (Davenport et al. 2006).  The sample 
can be collected non-invasively by simply cutting a ~1cm diameter sample of hair 
at the base of the vertex posterior of the head.  This eliminates the risk that the 
sampling itself may have an impact upon cortisol production.  Furthermore, as 
each centimeter sample represents approximately one month’s worth of cortisol 
production, the issue of intra- and inter-day cortisol fluctuations is mitigated.  
Finally, unlike the bodily fluids that require special storage conditions prior to 
analysis, hair samples are easily transported and stored in envelopes or vials at 
room temperature (Gow et al. 2010).  A summary of the different properties of 
existing matrices for cortisol measurement is presented in Table 1. 
Another matrix that may be capable of providing cumulative cortisol 
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exposure is fingernails.  Recently a pilot study was performed to determine 
whether cortisol and dehydroepiandrosterone (DHEA) could be detected in 
fingernails (Warnock et al. 2010).  Using a methanol extraction and ELISA, both 
cortisol and DHEA were detected in fingernails from 33 university students.  
During times of exam stress the ratio of cortisol over DHEA was found to be 
significantly increased compared to baseline levels obtained at the beginning of 
the school year.  One of the limitations that the authors noted was how fingernail 
growth is known to change depending on environmental factors (e.g. seasonal 
changes) and differences in personal behaviour (e.g. nail-biting habits).  Thus, 
controlling for such variables would be important for fingernail cortisol 
concentrations to accurately reflect time periods of interest.  Another study used 
a Sorenson buffer extraction and ultra-performance mass spectrometry analysis 
to investigate whether cortisol, cortisone, and DHEA could be detected in 
fingernails (Ben et al. 2011).  The median cortisol concentration was 69.5pg/mg 
(36-158pg/mg) and the median cortisone concentration was 65pg/mg (32-
133pg/mg).  Further studies are required to validate fingernails as a reliable 
matrix, but they may present an alternative for cumulative cortisol measurement 
when hair analysis is not possible, such as in cases of balding or cultural 
objections against hair sample collection.   
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Table 1.  A comparison of properties of the various matrices for cortisol measurement 
Property Serum Saliva Urine Hair 
Subjective level of 
invasiveness associated with 
sample collection 
High Low Moderate Low 
Cortisol affected by stress of 
sampling procedure? 
Possibly Possibly Possibly No 
Storage requirements Spinning and 
refrigeration followed 
by freezing 
Refrigeration or 
freezing 
Refrigeration or 
freezing 
Room 
temperature; 
stable for years 
Time periods of cortisol 
production represented 
Single point measure Single point 
measure 
12-24 hours; integral 
of exposure 
Months to years; 
integral of 
exposure 
Affected by changes in 
cortisol binding globulin? 
Yes; total cortisol 
measured 
No; only free 
cortisol measured 
No; only free cortisol 
measured 
No; only free 
cortisol measured 
Clinically relevant reference 
ranges established? 
Yes Yes Yes No 
1.3.3 Lab Procedure 
Overall, the methods used for measurement of cortisol in hair are very 
similar, with some variations in procedures among laboratories.  Briefly, to extract 
cortisol from hair, the sample is carefully sectioned into segment lengths that will 
approximate the time period of interest (e.g. the most proximal 3cm for the last 3 
months of cortisol production).  Then, the hair is finely minced with scissors or 
ground with a ball mill, and incubated in a solvent such as methanol.  The 
resulting solution is evaporated to dryness, and then reconstituted in a solution 
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such as phosphate buffered saline (Sauve et al. 2007).  Following the extraction, 
ELISA, RIA, or LC-MS/MS have all been used for cortisol quantification (Gow et 
al. 2010).  Presently, there can be significant interassay variability in the 
commercially available immunoassays.  The immediate implication is that 
researchers in this field must try to perform all tests of a particular protocol using 
the same batch of cortisol immunoassay, using internal positive controls as 
standards, and preferably using assays that have low interassay variability.  
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Chapter 2: Literature Review 
Parts of this chapter have been published: 
Russell E, Koren G, Rieder M, Van Uum S. Hair cortisol as a biological marker of 
chronic stress: Current status, future directions and unanswered questions. 
Psychoneuroendocrinology 2012. 37:589-601.  
2.1 Emergence of Hair Cortisol Analysis to Detect Clinical or Stress-Mediated 
Changes in Cortisol  
2.1.1 Observational Studies: 
Kirschbaum and colleagues investigated if the well-established increase in 
cortisol production in the third trimester of pregnancy could be detected using 
hair cortisol analysis (Kirschbaum et al. 2009a).  Mothers who had recently given 
birth provided hair samples that were divided into section lengths corresponding 
to their first, second, and third trimesters.  These samples were then paired 
against nulliparous women and the hair cortisol concentrations were compared.  
The cortisol concentrations in the section of hair corresponding to the third 
trimester were significantly higher when compared to earlier trimesters and when 
compared to non-pregnant controls (t(1,120)=4.77; P<0.001) (Kirschbaum et al. 
2009b). While this study was appropriately designed to assess the effect of 
pregnancy on hair cortisol content, an effect of repeated hair washings on hair 
cortisol along the hair shaft (when comparing sections obtained from a single hair 
sample) cannot be ruled out. This limitation was not present in the study by 
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D’Anna-Hernandez et al. (2011) who took hair samples at the end of each 
trimester of pregnancy and compared hair cortisol changes throughout 
pregnancy and the postpartum period.  Hair cortisol concentrations were found to 
be significantly elevated in the third trimester relative to the first trimester (t=4.1; 
P<0.001) and decreased again in the postpartum period (t=2.9; P=0.004).  
Stalder et al. (2010) investigated hair cortisol concentrations in alcohol-
dependent subjects in acute withdrawal compared to long-term abstinent 
alcoholics and a control group of matched non-alcoholic subjects.  The study 
rationale was that alcoholics in acute withdrawal have been documented to be 
hypercortisolemic. Indeed, the samples from the alcoholics in acute withdrawal 
revealed significantly higher cortisol concentrations when compared to both the 
abstinent alcoholics and controls (51.99±43.30 vs. 13.98±10.63, 
16.55±12.59pg/mg, respectively; P<0.001).  
Finally, hair cortisol content was also significantly increased in patients with 
Cushing’s syndrome, a condition characterized by the endogenous 
overproduction of cortisol (Thomson et al. 2010). Similarly, Manenschijn et al 
also found significantly elevated hair cortisol concentrations in a group of 9 
patients with Cushing’s Syndrome as compared to 195 non-Cushing’s controls 
(P<0.0001) (Manenschijn et al. 2011b).  In aggregate, these studies support the 
notion that cortisol in hair provides a reflection of long-term systemic cortisol 
exposure.   
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2.1.2 Intervention Studies  
The first experimental animal study that demonstrated that hair cortisol can 
change following an intervention was published by Davenport et al (Davenport et 
al. 2006). They studied rhesus macaques that had recently undergone relocation 
from their original housing environment, and were displaying behavioral 
characteristics of increased stress.  Three hair samples were obtained: one 
representing the 13 weeks before the relocation, one representing the 14 weeks 
immediately after relocation, and one taken a year after the relocation.  A 
significant increase in cortisol concentration was observed in the 14-week post-
relocation samples compared to baseline levels (129.6±15.5 vs. 81.1±7.5pg/mg, 
respectively; P<0.001), and one year following the re-location the cortisol levels 
approximated the pre-relocation levels again.  These results documented not 
only that stress is associated with increased hair cortisol concentrations, but also 
that hair cortisol content responds dynamically to changes in cortisol over time. 
Two recent studies in rhesus macaques studied the effect of maternal 
separation on hair cortisol levels of the infants. In the first study, the macaques 
were reared from birth onwards by either their mothers and their peers, just their 
peers, or by surrogate peers.   At 8 months of age, all macaque groups were 
placed in a large common social environment.  Compared to the other two 
groups, macaques that were raised by their mothers exhibited reduced anxious 
behavior following relocation and had lower hair cortisol both before and after the 
placement in the large. In infants raised by peers only, hair cortisol before 
separation were positively correlated with later composite anxiety (Dettmer et al. 
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2011). In the second study, peer-raised infant macaques had lower hair cortisol 
(measured at 18 month age) than those raised by their mothers. The peer-raised 
macaques demonstrated abnormal stress-response and decreased socialization 
behavior at 3 years of age (Feng et al. 2011). Thus, the direction of the HPA axis 
activity (hyper- or hyposecretion) may vary in relation to age, anxiety and social 
situation. 
Of note, short-term increases of cortisol following brief stressors cannot be 
detected by measurement of cortisol in hair. This is illustrated by a recent study 
in caribou and reindeer that received a single injection of ACTH. This did not 
affect hair cortisol, suggesting that hair cortisol is not sensitive enough to detect 
minor or short-lived alterations of the HPA axis (Ashley et al. 2011).   
Laudenslager et al investigated the relation between hair cortisol and 
novelty seeking behavior (Laudenslager et al. 2011).  They used a standardized 
test to determine the response of female vervets to a potentially dangerous 
foreign object. This generated a Novelty Seeking Score, with higher scores 
indicating a greater tendency to explore the object. Next, novelty-seeking 
behavior was correlated with hair cortisol as a tool to assess long-term HPA axis 
activity. Vervets with low hair cortisol concentrations had significantly higher 
Novelty Seeking Scores than vervets with high cortisol concentrations (P<0.01).  
These results suggest that a dampened HPA response may be associated with 
more bold behaviour and that consistently elevated HPA activity may inhibit the 
ability or willingness to examine novel challenging circumstances.  This study 
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demonstrates the ability of hair cortisol analysis to be used as a tool to expand 
the animal paradigm of human novelty seeking behaviour. 
 Work on the same vervets has been continued by Fairbanks et al 
examining the heritability of HPA activity in response to a stressor (Fairbanks et 
al. 2011).  The 226 female vervets used were living in a colony of 16 
multigeneration, matrilineal social groups.   Hair cortisol analysis was used to 
measure cortisol concentrations before and after relocation to another housing 
facility across the country.  This process was thought to be stress-inducing 
because of the required multiple anesthetizations, transportation, and interaction 
with unfamiliar staff.  Pre-move hair samples were collected to establish a 
baseline, and post-move hair samples were taken 25-29 weeks after the 
relocation, a study design similar to the rhesus macaque study by Davenport et 
al. (Davenport et al. 2006).  The added facet of this study was that the pedigree 
of individual vervets was delineated with the use of microsatellite markers to 
determine paternal and maternal contributors to each vervet’s DNA.  As 
expected, mean cortisol concentrations were significantly elevated post-move 
(27% increase; P<0.001).  Additionally, when examining genetic influences in 
hair cortisol levels, there was a significant concordance in both the baseline 
(h2=0.13; P<0.001) and the post-move (h2=0.13; P<0.001) cortisol concentrations 
amongst vervets with similar genetic complements (Fairbanks et al. 2011).  This 
study validated results from previous studies indicating the stress of moving and 
more importantly demonstrated a genetic influence governing hair cortisol 
concentrations.  This may prompt human studies to determine the extent to 
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which hair cortisol concentrations are governed by genetics, independent of 
environmental factors.   
 The ability of hair to effectively detect changes in cortisol concentrations 
has been convincingly demonstrated in several proof-of-concept human studies.  
One such study by Thomson et al. involved patients with Cushing’s Syndrome 
(Thomson et al. 2010).  In this study, hair samples were obtained from patients at 
the time of first presentation in the clinic.  When analyzed month by month, a 
steady increase in cortisol concentration was observed up until the point of 
presentation, consistent with clinical symptoms of increasing cortisol exposure.  
Following a successful surgical intervention to correct the condition another hair 
sample was obtained, and the cortisol content of those samples was significantly 
reduced.  This was corroborated by Manenschijn and colleagues, who took hair 
samples during the clinical course of a patient with Cushing’s disease 
(hypercortisolism caused by a pituitary ACTH producing adenoma).  Hair cortisol 
concentrations were elevated initially, and showed a marked decline following a 
corrective surgery (Manenschijn et al. 2011b). 
2.2 Methodological Challenges in Hair Cortisol Analysis 
 From its inception as a tool to monitor stress and cortisol concentrations 
there have been some persistent questions about the nature of hair cortisol 
analysis and the underlying (patho-)physiology. 
A frequently raised question is the mechanism by which cortisol enters the 
hair.  Several mechanisms have been proposed (Fig. 1). 
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The most commonly suggested hypothesis is based upon the complex 
multi-compartment model that has been used to explain drug incorporation in hair 
(Boumba et al. 2006).  Cortisol is thought to enter hair primarily at the level of the 
medulla of the hair shaft via passive diffusion from blood.  In this scenario hair 
cortisol would be hypothesized to reflect the integrated free cortisol fraction 
rather than the total cortisol concentration in serum. Additional cortisol may coat 
the outer cuticle from sebaceous and eccrine secretions (Pragst and Balikova 
,2006;Raul et al. 2004).  However, to date no studies have been conducted to 
confirm that cortisol is present in sebum or sweat.   
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There has been some discussion as to whether the cortisol found in hair is 
representative of systemic concentrations. Most authors assume that hair cortisol 
content is representative of systemic levels. However, local cortisol production 
may participate as well, particularly as Ito et al demonstrated that hair follicles 
contain a functional equivalent of the HPA axis and can synthesize cortisol after 
stimulation by Corticotrophin-Releasing Hormone (CRH) (Ito et al. 2005).  This 
was supported by a study by Sharpley et al. in which three subjects were 
subjected to a cold pressor test (CPT), in which their hand was immersed into a 
container of ice water for one minute (Sharpley et al. 2009).  Six minutes prior to 
the test, baseline levels were obtained by taking a saliva sample (meant to 
represent central HPA activity), a hair sample from the wrist that was going to be 
immersed (meant to represent peripheral HPA activity), and a hair sample from 
the opposite leg (meant to represent the control for peripheral HPA activity).  
Immediately following the test, samples were collected again from the 
aforementioned areas, and 6 additional samples were collected from each 
participant over the following 30 minutes.  Of interest, the hair cortisol 
concentrations for the wrist that underwent the CPT were markedly elevated from 
the baseline immediately following the CPT in each of the 3 participants.  These 
concentrations then proceeded to decrease over the course of the next 30 
minutes.  No changes were observed in the hair samples taken from the opposite 
leg which did not experience the CPT.  Salivary cortisol levels did not appear to 
correlate with the hair measures.  The authors postulated that this might 
demonstrate a peripheral HPA activity influencing hair cortisol levels in a 
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transitory way, independent of central HPA activity.  A caveat for this study is that 
a control experiment assessing the effect of non-stressing (e.g. room or body 
temperature) immersion in water was lacking. Additionally, the hair examined 
was from the participants’ arms, and compared it with hair from their legs—hair 
from these locations is differently regulated than scalp hair.  Further, the number 
of participants was small and the experiment still requires confirmation.  Finally, 
very high hair cortisol concentrations were found in a patient receiving treatment 
with high dose hydrocortisone (Thomson et al. 2010). In this clinical scenario the 
CRH production is suppressed so that the hair bulb HPA unit would not be 
stimulated by CRH and thus produce none or very little cortisol. Moreover, recent 
data from a patient with primary adrenal insufficiency, with elevated ACTH, 
showed low hair cortisol levels, supporting the evidence that cortisol levels 
detected in hair are primarily from central HPA activity (Manenschijn et al. 
2011b). The effect of natural hair color or cosmetic treatments on hair cortisol 
concentrations is another frequently debated topic.  With respect to natural hair 
colour, neither Sauvé and colleagues nor Manenschijn et al. have detected 
significant differences in cortisol levels due to natural coloration (Sauve et al. 
2007;Manenschijn et al. 2011b).  In dogs, Bennet et al. found that hair 
pigmentation has a significant impact on cortisol concentration, with black 
(eumelanin), agouti (mixed melanin content), and yellow (pheomelanin) hairs 
showing an ascending hair cortisol concentration (r=0.47; P=0.001) (Bennett and 
Hayssen ,2010).  This was the first study to suggest that melanin content could 
impact how cortisol is sequestered into hair.  Sauvé et al. demonstrated that 
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cosmetic treatments such as hair dying have been shown to significantly 
decrease hair cortisol levels relative to controls (P<0.036) (Sauve et al. 2007).   A 
similar trend that failed to reach significance was noted by Manenschijn et al. 
(Manenschijn et al. 2011b)  A possible mechanism for this decrease could be 
that cosmetic treatments such as bleaching may increase the porosity of hair, 
allowing more cortisol to be leached out (Boumba et al. 2006), or that they add 
weight to the hair causing a dilution-like effect.   
Wildlife studies using point measures of cortisol to examine the 
relationship between basal cortisol concentrations and organic pollutants have 
frequently suffered from the confounding effect of the stress induced by the 
chase to anesthetize the animal.  As hair cortisol measurement can potentially 
overcome this confounder, two studies measured hair cortisol in bears to 
determine factors that affect hair cortisol content. Hair cortisol was found in both 
studies, and isopropranolol wash eliminated any contribution from contamination. 
These studies did not find any affect of age or hair colour on hair cortisol in 
bears. In grizzly bears, hair cortisol content was affected by body hair type (with 
lowest hair cortisol variability for guard hair), body region and capture method 
(Macbeth et al. 2010). Interestingly, female polar bears had higher hair cortisol 
than male polar bears (Bechshoft et al. 2011), while in grizzly bears such a 
difference was not found This may perhaps be explained by a difference in 
pregnancy states, as hair cortisol in humans and primates increases with 
pregnancy, but information on pregnancy state was not provided in these studies.  
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Since personal hygiene is quite variable from person to person, it is 
important to known what effect, if any, frequency of hair washing has on hair 
cortisol concentrations.  In rhesus macaques, Hamel et al. have shown that 
repeated washing with either shampoo or water decreased hair cortisol 
concentration (Hamel et al. 2011).  Hair samples from 20 different macaques 
were collected, and hair shavings were divided into 4 different pools of hair with 
hair from 5 different macaques contributing to each pool.  Hair samples from 
each pool were placed in separate test tubes and subjected to 20 water washes 
and 10, 20, and 30 shampoo washes with a 10% shampoo solution.  A wash 
consisted of a 10ml addition of the solution, inversion for 45 seconds, and 
decanting.  For the test tubes with shampoo additional water washes were used 
to remove any residual shampoo.  Upon analysis, non-washed control samples 
had significantly more cortisol than any of the wash treatments in all 4 pools 
(P<0.001).  Additionally, hair that had been washed with shampoo 30 times had 
significantly less cortisol than that which had been only washed 10 times 
(P<0.005) in all four pools. This finding implies that information on the frequency 
of hair washing should be collected when conducting hair cortisol analysis 
studies.  A follow-up study to replicate these results in humans would be prudent, 
since macaques and humans have very different baseline levels of hygiene. 
Though the mean hair growth rate averages about 1cm/month, variations 
in hair growth profile do exist, and may in certain circumstances need to be 
accounted for.  Hair growth varies on different regions of the scalp, but consistent 
sampling from the vertex posterior should overcome intra-scalp differences.  
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When sampling from different populations, taking note of the ethnic background 
will be important, as African, Asian, and Caucasian individuals have different hair 
growth rates (288±51, 421±53, 371±59µm/day, respectively) (Loussouarn et al. 
2005). In addition, it is possible that clinical conditions affect hair growth rate, as 
suggested by a study in Angora goats in whom hyperthyroidism resulted in 
increased mohair fiber growth (Puchala et al. 2001). 
Maybe the most contentious methodological debate surrounding hair 
cortisol analysis pertains to whether cortisol concentrations remain constant 
along the length of the hair shaft.  Kirschbaum et al. examined hair cortisol 
concentrations along the hair shafts of 9 nulliparous women (Kirschbaum et al. 
2009a).  Hair samples of at least 18cm length were collected from each woman 
and divided into six 3cm sections.  In the first segments, cortisol concentrations 
decreased continuously (P<0.0001), 30-40% each time, reaching an asymptotic–
like level in the final two most distal segments.  The authors suggested that this 
decrease was likely due to a leaching effect, where more distal hair segments 
had experienced greater environmental damage, compromising the hair integrity.  
Thus, they suggested using only the most proximal 1-6cm of hair to reliably 
estimate systemic cortisol concentrations.  Gao et al. found similar results with 
segmental analysis of 5 subjects (Gao et al. 2010).  The first five 1cm segments 
experienced an average linear hair cortisol decline of -2.7±0.3pg/cm (β=-0.98; 
P<0.01).   In contrast, several studies have contradicted these results.  Thomson 
et al., recruiting 9 healthy control subjects with hair lengths ranging from 10-
14cm, could not confirm the previous studies (Thomson et al. 2010).  Hair 
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samples were segmented into 1cm sections and of the 9 healthy controls, 8 had 
no significant differences in cortisol concentration along the length of the shaft 
(mean for all sections 147±46ng/g); one participant did demonstrate a significant 
decrease (P<0.05) over time.  Similarly, Manenschijn et al. could not show time-
dependent changes (Manenschijn et al. 2011b).  A group of 28 women provided 
hair samples at least 18cm in length, and these were then segmented into six 
3cm sections.  No significant differences in hair cortisol concentration were 
observed in consecutive segments (P=0.249). Adding to the argument that 
cortisol does not naturally vary in distribution along the length of the hair shaft, 
both a study in rhesus macaques (Davenport et al. 2006) and a study in dogs 
(Bennett and Hayssen ,2010) found no significant differences between the most 
proximal half and the most distal half of the hair shaft. However, these animal 
studies may not necessarily translate to the human condition, as the hair length 
and the hygiene in the animals may be considerably different from humans.  The 
dog hair length of 2.3-4.3cm is shorter than in many human samples, and the 
argument surrounding a significant decrease in hair cortisol concentration is most 
often applied to segments beyond 6cm distal from the scalp.  While further 
studies are needed to resolve this controversy there is a wide consensus that the 
first 5-6cm of hair away from a person’s scalp can reliably reflect HPA activity. 
Finally, the question of stability of cortisol over longer durations of time 
has also arisen.  This question was effectively addressed by a study performed 
by Webb and colleagues who obtained hair samples ranging in length from 6 to 
21cm from 10 ancient Peruvian mummies, dating from AD550-1532 (Webb et al. 
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2011).  Segmental analysis was performed on the hair samples provided, and 
while variation was observed from segment to segment, proximal and distal 
segments were not significantly different.  The mean cortisol concentration 
determined was 281±35ng/g, similar to those measured by the same laboratory 
in healthy volunteers today, demonstrating that cortisol can even be extracted 
from hair over thousands of years old. 
2.3 Hair Cortisol Analysis in Clinical Sources of Stress 
 While hair is still a relatively new means of measuring cortisol, several 
human studies have shown its ability to identify important pathophysiological 
sources of stress. 
Kalra et al were the first to correlate cortisol levels in hair with self-reported 
stress using the Perceived Stress Scale (PSS), a validated self-report 
questionnaire of an individual’s stress level over the past month (Cohen et al. 
1983).  In that study, 25 healthy pregnant women were assessed around the time 
of late first trimester to early second trimester (Kalra et al. 2007).  They provided 
a hair sample representing the last month’s worth of cortisol production and also 
filled out a PSS.  There was a significant correlation between hair cortisol 
concentration and PSS score (rs=0.47; P<0.05). The concordance between 
cortisol as a measure of stress and a self-report measure indicated that hair 
cortisol analysis might provide a good assessment of an individual’s chronic 
stress level. 
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Kramer and colleagues sought to examine whether higher cortisol 
concentrations might predict spontaneous pre-term birth (Kramer et al. 2009).  
Levels of maternal CRH are reportedly elevated in such cases, so it could be 
expected that cortisol concentrations in the hair might be found in higher 
concentrations as well.  The case group consisted of 207 women who 
spontaneously began labor prior to 37 weeks in their pregnancy, and the control 
group consisted of 444 women who initiated labor at term.  Hair samples were 
obtained (most proximal 9cm to the scalp), a PSS was completed, and a 
pregnancy-related anxiety assessment was performed.  Hair cortisol 
concentrations of the case and control groups were not significantly different, nor 
were hair cortisol concentrations significantly associated with PSS scores or 
anxiety assessments.  This study demonstrates how in some instances hair 
cortisol analysis on its own may not be able to detect stress in cases where the 
etiology of prematurity is multifactorial and where every woman experiences 
elevated cortisol production in late pregnancy, irrespective of stress. 
A stay in the neonatal intensive care unit (NICU) is thought to be stressful in 
infants because they endure a series of diagnostic and/or therapeutic procedures 
that are often painful and highly stressful.  To examine whether this stress could 
be quantified, Yamada et al. compared hair cortisol concentrations of infants 
requiring a stay in a NICU with those of healthy infants born at term (Yamada et 
al. 2007).  The cortisol concentrations of the NICU group were significantly higher 
than the control (2.06±2.05 vs. 0.11±0.42nmol/g, respectively; P=0.004). Of note, 
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the infants in the NICU group were born at younger gestational age than the 
control group, which could create a potential confounding effect. 
Another study looking to capture the stress effects of chronic pain using hair 
analysis was performed by Van Uum et al. who recruited adult patients who were 
using opioids to help control severe chronic non-cancer pain and compared them 
to non-obese controls (Van Uum et al. 2008).  A hair sample was obtained in 
both groups, and the PSS questionnaire completed.  The patients with chronic 
pain had significantly higher mean hair cortisol concentrations than the controls 
(83.1 vs. 46.1pg/mg) and their PSS scores indicated significantly more stress 
relative to the controls as well (P<0.001).  This lends powerful support to the 
notion that hair cortisol concentrations can provide an indication as to an 
individual’s perceived stress level.  
Recently, Pereg et al. investigated the role of chronic stress as measured 
by hair cortisol, in the development of an acute myocardial infarction (AMI) 
(Pereg et al. 2011).  As chronic psychosocial stressors (e.g. financial concerns, 
marital stress, job stress) are frequently listed as risk factors for AMIs, the 
authors hypothesized that hair cortisol analysis could potentially be a useful tool 
to quantify these stressors.  Hair samples representing the past 3 months of 
cortisol production were obtained from patients within 2 days of admission to a 
hospital for chest pain.  The study group consisted of 56 patients who had a 
confirmed AMI, with a control group consisting of 56 patients in whom chest pain 
was attributed to other causes.  Median cortisol concentration of the AMI group 
was significantly higher than that of the control group (295.3 vs. 224.9ng/g; 
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P=0.006).  In logistic regression, accounting for age, lipid status, smoking, and 
other predictors, hair cortisol was the strongest predictor of AMI, followed by BMI.  
It should be emphasized that the hair cortisol measurement reflected the 3 
months before the heart attack, and not the stress caused by the heart attack.  
Thus, this suggests that chronic stress plays a causative role in the 
pathophysiology of AMI.  This type of information cannot usually be obtained 
using other matrices, except as part of a prospective study, as illustrated by the 
predictive effect of urinary cortisol excretion on cardiovascular morbidity and 
mortality (Vogelzangs et al. 2010). 
 Hair cortisol analysis was also used by Dowlati et al. to assess its potential 
to predict depressive symptoms in patients suffering from coronary artery 
disease (CAD), a population far more at risk of depression (Dowlati et al. 2010).  
Depressive symptoms were demonstrated in 34 of the 121 patients with CAD.  
The most proximal 3cm of hair were obtained from each patient and hair cortisol 
concentrations were determined.  When comparing depressed and non-
depressed CAD patients, no significant difference in hair cortisol concentration 
was observed between these two groups. It was postulated that the general 
psychosocial stress associated with CAD, irrespective of the presence of 
depression, might have masked any actual differences in cortisol production 
between these two groups. 
 Hair cortisol analysis has been used to determine to what extent chronic 
stress is related to the nasal carriage of Staphylococcus aureus, a common 
bacterial infection.  Manenschijn and colleagues predicted that since higher 
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cortisol levels are associated with immunosuppression, the long-term carriers of 
Staphylococcus aureus would likely have the highest hair cortisol levels 
(Manenschijn et al. 2011a).  Of 72 healthy subjects, 38 were non-carriers, 10 
were intermittent carriers, and 24 were long-term carriers of Staphylococcus 
aureus.  An analysis of hair segments representing the last 3 months of cortisol 
exposure, no significant differences were detected amongst the 3 groups of 
carriers (F2,66=0.425; P=0.638).  The authors concluded that higher cortisol levels 
might not play a significant role in the degree of Staphylococcus aureus 
colonization. 
 Van Rossum and colleagues employed hair cortisol analysis to investigate 
patients with bipolar disorder, a condition in which HPA dysregulation may play 
an etiological role (van Rossum et al. 2011).  The most proximal 3cm of hair was 
collected from 100 bipolar patients and 195 healthy controls and hair cortisol 
concentrations were determined.  There were no significant differences between 
bipolar patients and healthy controls (31.84pg/mg vs. 28.18pg/mg; P=0.23).  
However, when the bipolar group was split into subgroups in which onset 
occurred before or after the age of 30, significant differences were noted.  
Patients with bipolar disorder diagnosed after 30 had significantly higher cortisol 
concentrations than those diagnosed before 30 or the healthy controls (P=0.004). 
This led the researchers to suggest that HPA dysregulation may be relevant in 
older onset patients, and this maybe represent a different disease entity 
altogether. 
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2.4 Hair Cortisol Analysis for Monitoring of Glucocorticoid Replacement Therapy 
In addition to its role in monitoring stress, hair cortisol analysis is being 
explored as a means of monitoring the treatment of patients with adrenal 
insufficiency (AI).  Patients with AI suffer from inadequate cortisol production, 
either due to disease of the adrenal gland itself (‘primary’) or due to an 
inadequate production of ACTH, the hormone secreted from the pituitary gland 
stimulating adrenal cortisol secretion.  Since patients do not produce sufficient 
glucocorticoid to sustain normal homeostasis, a replacement therapy, often 
hydrocortisone, is required to ensure physiological well-being and survival.  
Because there are currently no effective measures to monitor long-term 
glucocorticoid exposure in these patients, Gow et al. examined whether hair 
cortisol analysis could fill this void (Gow et al. 2011).  A total of 93 patients with 
AI were recruited, and their partners were used as controls.  Median hair cortisol 
concentrations were increased in AI patients (230.7 [22.7-1377] ng/g) as 
compared to controls (184.7[57.7-14790]ng/g), but the difference failed to reach 
statistical significance (P=0.08).  Further, in the female subgroup there was a 
significant positive correlation between daily dose of hydrocortisone (mg/day) 
and hair cortisol concentrations (r=0.28; P=0.01).   These results indicate that 
patients with AI are often overtreated with glucocorticoid replacement, potentially 
making them more prone to comorbidities associated with long-term 
glucocorticoid exposure, such as changes in glucose and lipid metabolism, 
clinically important osteoporosis, and neuropsychiatric effects.    
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Similarly, a study by Manenschijn et al. supported the finding that hair 
cortisol concentrations can be used to monitor hydrocortisone replacement in 
patients (Manenschijn et al. 2011b). They recorded a case of a patient 
developing adrenal insufficiency who became hypocortisolemic and required 
glucocorticoid replacement therapy.  Hair samples taken at time points along this 
patient’s clinical course showed gradually decreasing hair cortisol concentrations 
before the intervention, with concentrations increasing after start of 
hydrocortisone treatment. Overall, these studies indicate that not only can hair 
cortisol analysis be a useful tool in detecting and monitoring stress, but also may 
play an important role in the monitoring and management of diseases of the 
pituitary-adrenal axis. 
2.5 Hair Cortisol Analysis to Identify Psycho-social Sources of Stress 
Financial and work-related concerns are subjectively the most common 
causes of social stress experienced by individuals today.  Dettenborn and 
colleagues used hair cortisol analysis to rate levels of psychological stress 
(Dettenborn et al. 2010).  Individuals who had been unemployed for at least one 
year were compared with currently employed control subjects.  All participants 
provided a hair sample and rated their level of chronic stress with the Trier 
Inventory for the Assessment of Chronic Stress (TICS) and a PSS.  Cortisol 
concentrations in hair segments representing the most recent 3 months and the 
most recent 3-6 months were significantly higher in the unemployed group 
(eta2=0071; P<0.05 and eta2=0.085; P<0.05 respectively).  Additionally, the 
unemployed group reported significantly higher levels of worry on the TICS 
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subscale (P<0.01) and had significantly higher scores on the PSS (P<0.01).  In 
this study, hair cortisol analysis was shown to be a powerful tool in measuring 
chronic stress resulting from a common psychological stressor, further indicating 
it effectiveness as a biomarker of chronic stress. 
Steudte and colleagues recently investigated hair cortisol concentrations in 
patients with Generalized Anxiety Disorder (GAD), a condition marked by 
excessive worry and anxiety regarding a variety of life problems (Steudte et al. 
2011b).  These symptoms are thought to be stressful in nature, but the literature 
examining its effect on the HPA axis is mixed, with some studies suggesting an 
overactive HPA axis and others finding no aberrations to the HPA axis.  The 
researchers collected 9cm hair samples from 15 patients with GAD and 15 age-, 
gender, and lifestyle-matched controls.  These samples were then divided into 
3cm segments and analyzed for cortisol content.  Additionally, all participants 
completed a PSS.  Interestingly, despite the GAD group having significantly 
higher mean PSS scores than the control group (P<0.001), their mean hair 
cortisol content in the two most proximal 3cm segments of hair was significantly 
lower than in the control subjects (P<0.01).  This is a new finding to this area of 
research, and suggests that while GAD patients have higher perceived stress, 
they may actually be hypocortisolemic.   This could be the result of down 
regulation of the HPA axis with chronic anxiety, as evident in the recent meta-
analysis (Miller et al. 2007).  These studies highlight how hair cortisol analysis 
may provide new insight and perspectives to support or challenge mechanistic 
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notions on stress response in various conditions, and underscores the need to 
expand this body of research.   
The unique ability of hair cortisol analysis to examine temporally distant 
psychological stressors has been perhaps best exemplified with a recent paper 
by Steudte et al. (Steudte et al. 2011a).  Ugandan civil war survivors, many of 
whom had been severely traumatized within the past year, were examined.  
Traumatized participants were ranked on a Clinician-Administered Posttraumatic 
Stress Disorder Scale to delineate those who had posttraumatic stress disorder 
(PTSD).  Sociodemographic background information known to affect cortisol 
production including age, sex, body mass index, smoking status and alcohol 
consumption was also collected.  In addition, a four point PSS, Hopkins 
Symptom Checklist for depression and Mini-International Neuropsychiatric 
Interview for suicidal ideation were all conducted.  The specifics of the traumatic 
events that each participant had experienced were recorded, and the most 
proximal 3cm of hair were used to represent cortisol production over the past 15 
weeks.  In total 10 PTSD patients and 17 controls were included for the analysis.  
Traumatized patients with PTSD were found to have significantly higher hair 
cortisol concentrations than their paired traumatized controls without PTSD 
(F(1,25)=5.35; P<0.05; ηp2=0.18) .  In addition, in both groups the number of 
lifetime traumatic events was positively correlated with hair cortisol concentration 
(r=0.41; P<0.05).   
These findings are significant because this was the first time that hair 
cortisol analysis was used to investigate patients with PTSD, and the results 
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stood in stark contrast to most other studies that have found PTSD to be 
frequently associated with hypocortisolism (Mason et al. 1986;Yehuda et al. 
1996;King et al. 2001).  Some have postulated that this aberrant finding about a 
disorder that is clearly stress-mediated may have been an artifact of sampling 
procedure.  Previously the only matrices used to examine cortisol concentrations 
in patients with PTSD were serum, saliva, or urine-all of which only provide a 
very narrow window into a patient’s cortisol production profile.  Steudte’s results 
are consistent with the systematic review by Miller et al. (2007) that, in a meta-
analysis of 107 studies on chronic stress, have shown that an important factor 
influencing cortisol output is the time that has elapsed since the stressful incident 
occurred.  When the source of the stress was ongoing or had been relatively 
recent, cortisol concentrations appear to be elevated, but when the source of the 
stress is temporally distant, lower cortisol concentrations are observed.  In the 
past, acquiring samples at the time that the stressful event (such as the Ugandan 
civil war) occurred has often not been logistically or ethically feasible.  Hair 
cortisol analysis has introduced a new tool to complement current methods for 
cortisol quantification and may provide a means to overcome some limitations of 
the established methods. Thus it may reinforce a potential paradigm shift 
suggesting that patients with PTSD may actually have started out with 
hypercortisolemia and have transitioned to hypocortisolemia. 
2.6 Limitations 
Hair is an exciting new matrix able to provide long-term retrospective 
measures of cumulative cortisol secretion.  However, several challenges need to 
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be considered when applying this novel biomarker of stress.  For instance, 
because psychologically-based measures of stress have only been validated for 
relatively short periods of days to weeks, they cannot serve as a gold standard 
against emerging methods such as hair cortisol analysis which measures stress 
levels occurring several months ago.  This may explain some of the observed 
inconsistencies in correlations between hair cortisol levels and psychological 
tests.  The heterogeneity in the types of psychological tests (e.g. PSS vs. Trier 
Social Stress Test) also presents a challenge when trying to directly compare 
studies from different research groups.  Additionally, in subjects who may be 
exposed externally to corticosteroids in the form of lotions or creams, external 
contamination of the hair shaft will preclude analysis. It is important to remember 
that this matrix is not capable of measuring acute changes in stress, and 
therefore if such changes need to be observed in additional to chronic stress, the 
other matrices for cortisol measurement should also be used. Finally, in subjects 
who are unable or unwilling to provide a hair sample, analysis is not possible – 
simply put, one cannot measure cortisol in hair if one has no hair! 
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Chapter 3: The Focus of the Present Work 
3.1 Methodological Challenges 
While hair cortisol analysis continues to prove to be a useful means of 
monitoring cortisol exposure as a marker of chronic stress, some methodological 
questions remain unanswered.  Even though the literature on hair cortisol 
measurement is growing quickly, there are still gaps in the knowledge that need 
to be addressed. First, the mechanism of cortisol incorporation in hair needs to 
be clarified. Further studies need to determine if and to what extent hair cortisol 
originates from blood, eccrine and/or sebaceous sources, if this is different for 
medullary versus cortical layers, and if hair cortisol is a reflection of total and/or 
free cortisol exposure. The paradigm for cortisol incorporation into hair has 
assumed that cortisol enters the medulla of the hair shaft via blood, and therefore 
hair analysis would reflect an integral of serum concentrations over time.  It has 
also been postulated that sebaceous and eccrine secretions may contribute to 
hair cortisol concentrations, but supporting evidence is lacking (Pragst et al., 
2006).  It is presently unknown what, if any, cortisol concentrations are found in 
human sweat.  Since individuals have various levels perspiration, personal 
hygiene, and hair washing frequencies, it would be important to assess to what 
extent sweat affects hair cortisol concentrations. 
Secondly, it is important to obtain more specific information on the extent 
to which hair cortisol varies along the hair shaft, and which factors determine this. 
This needs to include assessment of the effect of hair washing, both while the 
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hair is in situ, and during sample preparation before measuring hair cortisol. The 
degree to which washing procedures are required to negate the effects of 
external contamination, e.g. by blood, and saliva, needs to be determined, 
particularly for animal studies. Furthermore, there is a dearth of knowledge on 
the effect of factors such as ethnicity, age, sex, and seasonal influences on hair 
cortisol content. 
Immunoassays are commonly used to measure saliva, blood, urine, and 
hair cortisol concentrations.  These methods, while sensitive to changes, are 
presently subject to interassay variability, precluding a unified definition of 
physiologic ranges of levels.  Development of LC-MS/MS technology is likely to 
overcome this issue in the future. 
3.2 Clinical Uses  
As described previously, the effect of maternal separation in animals, and 
of psychological factors in both humans and animals on hair cortisol can vary in 
both direction and extent. This is a major area in need of increased 
understanding before this can be applied in clinical settings.   
With respect to application for patient care, the studies on the utility of hair 
cortisol measurement in diagnosis and treatment of Cushing’s disease and 
adrenal insufficiency need to be expanded and confirmed. In addition, the effect 
of other disease states, including malignancies, metabolic and sleep disorders, is 
currently unknown. 
39 
 
The majority of human studies using hair cortisol analysis as a chronic 
biomarker of stress are associative.  While initially such studies are important to 
try to identify some novel sources of stress, they cannot confirm causation or 
rectification of stress levels.  Rather, intervention studies are needed to 
understand what initiates cortisol release, and, more importantly, if and to what 
extent hair cortisol (as a reflection of systemic cortisol exposure) can be 
changed.  To date, only the relocation studies involving rhesus macaques and 
vervets, and the studies following the disease course of Cushing’s or adrenal 
insufficiency in response to treatment have been true intervention studies.  A 
greater emphasis on long-term intervention studies will expand the utility of this 
novel biomarker.  An excellent candidate condition to apply hair cortisol analysis 
to is obstructive sleep apnea (OSA). 
3.2.1 Obstructive Sleep Apnea Background 
Obstructive sleep apnea is a type of sleep-disordered breathing that is 
characterized by frequent decreases (hypopneas) or cessations (apneas) of 
breathing during the course of sleep.  The hyponeas and apneas are the result of 
a collapse of the upper airway that is due to a lack of neuromotor tone in the 
tongue and/or airway dilator muscles (Dempsey et al., 2010).  It is estimated that 
the prevalence of OSA is 3-7% and 2-5% in adult men and women, respectively 
(Punjabi 2008).  OSA is largely underdiagnosed with up to 82% of men and 93% 
of women having undiagnosed OSA (Young et al., 1997).  The prevalence 
increases dramatically to 41% in patients with a BMI in excess of 28.    Other risk 
factors include mandibular insufficiency, abnormalities in the soft tissue of the 
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upper airway, tonsillar and adenoid hypertrophy, and smoking (Young et al., 
2004). 
Untreated OSA has been independently identified as a risk factor for a 
number of comorbid conditions.  Associated sequelae include nighttime 
awakenings, excessive daytime somnolence, increased cardiovascular morbidity 
and mortality, and increased insulin resistance resulting in higher risks for 
metabolic syndrome and type II diabetes (Kezirian et al., 2010; Levy et al., 2009).  
Additionally, untreated OSA can complicate anesthetization, making intubations 
more difficult and respiratory depression more pronounced under anesthesia 
(Park et al., 2011). 
3.2.2 Diagnosis of Obstructive Sleep Apnea 
 Investigation of OSA is usually initiated if a patient presents with snoring.  
Daytime somnolence is another common complaint, and is quantified using the 
Epworth Sleepiness Scale (ESS), an 8 point questionnaire which assesses the 
patient’s tendency to fall asleep at inappropriate times of the day (Appendix X).  
Higher ESS scores indicate a higher degree of daytime somnolence (Johns, 
1991).  The presence of snoring, daytime somnolence and risk factors (e.g. 
obesity) present the impetus to send a patient for an overnight sleep student 
(polysomnography).   
Polysomnography is the standard test for diagnosing OSA and other forms 
of sleep-disordered breathing.  During a polysomnogram heart rate, respiratory 
rate, and oxygen saturations are monitored.  An electroencephalogram (EEG) 
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and electrooculogram (EOG) are used to discern the stages of non-rapid eye 
movement (NREM) sleep and rapid eye movement (REM) sleep.  The EEG is 
additionally used to monitor the presence of alpha, theta, and beta wave 
frequencies, and disturbances in these wave frequencies provide a means of 
assessing how many times a patient arouses from sleep.  Additionally, nasal 
pressure, esophageal pressure, and intercostal and abdominal muscle 
movements are recorded to aid in discerning between obstructive sleep apnea 
and central sleep apnea.  Finally, the combined number of apneas and 
hypopneas per hour are measured, generating a measure known as the apnea-
hypopnea index (AHI).  The severity of OSA is categorized based on AHI, with 
AHI scores less than 5 indicating the absence of OSA, 5-15 indicating mild OSA, 
15-30 indicating moderate OSA, and scores greater than 30 indicating severe 
OSA (Patil, 2010). 
3.2.3 Treatment of Obstructive Sleep Apnea 
Addressing modifiable risk factors is a universal treatment approach used 
for all severities of OSA.  Examples include exercise and healthy nutrition to 
promote weight loss, cessation of smoking, and decreased alcohol consumption.  
Modifying the sleep position from a supine position to a side position may also 
decrease the extent of upper airway obstruction.  Changes to medications that 
may promote weight gain or respiratory depression may also be discussed 
(Tuomilehto et al., 2009).   
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For patients who are unable to make the necessary lifestyle changes, or 
who require more aggressive treatment, continuous positive airway pressure 
(CPAP) is the standard of care.   CPAP machines are equipped with a mask that 
covers the nose and mouth of the patient.  Air travels through the mask in the 
direction of the patient’s upper airway, and the pressure generated maintains a 
patent airway (Parks et al., 2011).  Proper use of CPAP can significantly improve 
OSA, and decrease its associated morbidity and mortality.  Monitoring patient 
compliance is crucial, as it is highly variable.  The noise emitted by the machine, 
the pressure used, and the type of mask used may all need to be personalized to 
the patient’s preferences to enhance adherence (Shapiro & Shapiro, 2010).  A 
recent study by Sharma et al. (2011) demonstrated that 3 months of CPAP 
significantly improved the metabolic profile of individuals with metabolic 
syndrome when compared to a sham treatment.  Individuals on CPAP had 
significantly reduced systolic blood pressure, diastolic blood pressure, low 
density lipoprotein, triglycerides, and glycated hemoglobin.  Additionally, the 
symptoms of metabolic syndrome reversed in 13% of the participants on CPAP, 
compared to just 1% undergoing the sham therapy. 
Another treatment option is the use of an oral appliance, a device that 
advances the mandible forward, reducing the chance of an obstruction.  Oral 
appliances can significantly reduce AHI of a patient with OSA.  While not as 
efficacious as CPAP, they can serve as a primary treatment for patients with mild 
OSA, or be a complement to CPAP for moderate to severe cases (Hoffstein, 
2007). 
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Upper airway surgeries that remove or manipulate the tissues that may 
contribute to the airway obstruction, such as uvulopalatopharyngoplasty, 
maxillary-mandibular advancement, tonsillectomies, adenoidectomies, and 
septoplasty exist for patients with clear anatomical lesions.  The effectiveness of 
these procedures is highly variable depending on the patient population and the 
measure of success applied (Parks et al., 2011).  
3.2.4 Cortisol Secretion in Patients with Obstructive Sleep Apnea 
Several studies have hypothesized that the metabolic effects of sleep 
apnea may be mediated by increased cortisol secretion. In this model, the 
frequent sudden arousals during sleep activate the HPA axis result in increased 
cortisol secretion at night, at a time when cortisol secretion normally is very low 
(Trakada et al., 2007). As cortisol overproduction is associated with 
hypertension, metabolic syndrome and diabetes mellitus, cortisol is an important 
candidate mediator for the metabolic and cardiovascular effects of OSA (Lam et 
al., 2009).   
The interest in the relation between OSA and increased cortisol production 
has lead to studies investigating the possibility that therapeutic interventions such 
as CPAP can decrease cortisol production.  A recent study by Carneiro et al. 
(2008) examined 16 obese men with OSA and found that morning salivary 
cortisol concentrations were significantly less suppressed (P=0.012) by 
dexamethasone – pointing to increased cortisol production - than obese controls.  
Nine of the men were then placed on CPAP, and following a 3 month period the 
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endogenous cortisol production was more sensitive to suppression by  
dexamethasone, indicating lower, more physiologic level of activity of the HPA 
axis that now was comparable to the obese controls (Carneiro et al., 2008).  
Another study examined ACTH and cortisol production in 10 patients before and 
after being placed on CPAP.  Patients were monitored for 24 hours, with blood 
samples taken at 10-minute intervals.    After 3 months of CPAP patients had 
significantly reduced total serum ACTH (P<0.001) and total serum cortisol 
concentrations (P<0.001) (Henley et al., 2009).  Schmoller et al. (2009) also 
examined the effect that a CPAP intervention had on cortisol production.  Thirty-
eight patients were recruited and 6 salivary cortisol samples were collected 
throughout the course of the day before placement on CPAP, and another 6 after 
a 3-month period on CPAP.  The results were mixed, with the morning cortisol 
concentrations being significantly increased after CPAP (P=0.044), while evening 
cortisol concentrations were significantly reduced (P=0.038), overall indicating a 
change towards the normal diurnal cortisol rhythm. 
  Not all studies have indicated reduced cortisol concentrations after using 
CPAP.  A placebo controlled study of 101 male OSA patients sought to 
determine if serum cortisol concentrations were affected by nasal CPAP.  
Following a 4-week period, the change in serum cortisol concentrations of the 
placebo-controlled group was not significantly different from the treatment group.  
Additionally the study failed to detect an association between serum cortisol and 
OSA severity (as measured by oxygen desaturations)(Meston et al., 2003).  
Tasali et al. (2011) investigated the use of CPAP to improve the cardiac profile in 
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9 obese women with polycystic ovary syndrome who were diagnosed with OSA.  
One of the hormone markers investigated was cortisol.  Twenty-four hour blood 
monitoring, with 10-30 minute collection intervals, was done for one day before 
placement on CPAP and one day following an 8-week trial.  Following the CPAP 
trial, total serum cortisol concentrations were not significantly changed.   
While these studies garnered valuable pathophysiological information 
about OSA, the mixed results and small sample sizes make interpretation 
challenging.  Additionally, the serum collection was quite invasive, and both 
serum and salivary cortisol concentrations only represent a single point in time.  
A larger study, using a matrix, such as hair, may present a means of elucidating 
the role of the HPA axis in OSA, and if it can be modulated with CPAP therapy. 
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Chapter 4: Hypotheses 
There are two overall hypotheses in the present study.  Firstly, I 
hypothesized that the cortisol content of sweat will affect hair cortisol 
concentrations.  Secondly, I hypothesized that hair cortisol analysis can aid in 
elucidating the role of HPA activity and chronic stress in obstructive sleep apnea. 
4.1 Specific Objectives 
1. To determine the concentration of cortisol in sweat and its correlation with 
systemic exposure, as evidenced by salivary cortisol. 
2. To determine if hair that is more thoroughly coated with a hydrocortisone 
solution with a sweat-like cortisol concentration could appreciably increase 
the total cortisol concentration measured in hair. 
3. To determine if isopropanol washing effectively normalizes hair cortisol 
concentrations of hair samples which have been immersed in a sweat-like 
hydrocortisone solution. 
4. To collect hair samples from patients with OSA and determine if hair 
cortisol concentrations are related to clinical indicators of OSA severity. 
5. To determine what effect placing OSA patients on CPAP has on their hair 
cortisol concentrations and levels of perceived stress. 
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Chapter 5: Methods 
5.1 The Detection of Cortisol in Human Sweat—Implications for Measurement of 
Cortisol in Hair 
5.1.1 Ethical considerations   
The study protocol was approved by the University of Western Ontario 
Health Sciences Research Ethics Board (REB #17930E).  Each subject gave 
written informed consent. 
5.1.2 Subjects 
Athletes, both recreational and varsity, could be included if they were 18 
years of age and older.  Subjects were excluded if they used oral, parenteral, or 
topical glucocorticoids, if they had been diagnosed with Cushing’s Syndrome, 
and if they were pregnant. We obtained information on age, smoking status, and 
alcohol consumption, and measured height and weight and calculated body 
mass index.  
Saliva and sweat samples were collected immediately following a period 
of vigorous exercise, lasting 15-60 minutes.  Saliva samples were collected using 
the Alpco Diagnostics Saliv-SaverTM Collection Device.  The cotton swab was 
placed under the tongue, allowing it to saturate, and then placing it in a 5ml 
salivette.  Sweat samples were collected using another Alpco Diagnostics Saliv-
SaverTM Collection Device, but this time the cotton swab was rubbed over their 
scalp hair and necks, allowing it to saturate, and then pacing it in a 5ml salivette.  
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The salivettes were then centrifuged at 2218 g for 5 minutes, and 1ml of the 
supernatant was then pipetted into a 1.5ml Eppendorf tube.  Samples were 
stored at -20oC until analysis. 
5.1.3 Hydrocortisone Immersion and Hair Wash Experiments 
 To attempt to simulate the potential effects of hair exposure to sweat for 
an extended period of time, a hydrocortisone solution was constituted with a 
concentration of 50 ng/ml, a concentration consistent with low-mid range of 
sweat cortisol concentrations that were observed.  To accomplish this, 276µl of a 
hydrocortisone standard was dissolved in 100ml of phosphate buffered solution. 
The concentration of this solution was confirmed by analyzing it on an ELISA as 
per the method described below.  Residual hair samples (n=14) from past studies 
were used.  All of these hair samples had been collected from the vertex 
posterior of the scalp as per our standard protocol; these subjects had not been 
sweating before hair collection.  The most proximal 3 cm of hair were segmented 
and then subjected to one of five conditions: a control condition in which hair was 
washed then analyzed, and four treatment conditions in which hair samples 
where placed in 2 ml of the 50 ng/ml hydrocortisone solution for either 12 or 24 
hours, allowed to dry for at least 12 hours, after which they were either washed 
prior to analysis or analyzed without a wash. 
 Hair washing involved placing each hair sample in a scintillation vial, 
adding 3 ml of isopropranol, incubating it at room temperature at 0.28 g for 3 
minutes and decanting the isopropanol.  This procedure was repeated once and 
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then hair samples were allowed to air dry at room temperature for at least 12 
hours. 
5.1.4 Effect of Duration of Hydrocortisone Immersion 
 Residual hair samples (n=7) from past studies were used.  All of these hair 
samples had been collected from the vertex posterior of the scalp as per our 
standard protocol.  The most proximal 3 cm of hair were segmented and then 
subjected to one of five conditions: the control hair sample was briefly immersed 
in the 50ng/ml hydrocortisone solution for approximately 2 seconds and then 
immediately removed from the solution, and the other hair samples were 
immersed for 15, 30, 60, and 120 minutes, respectively.  Following the conditions 
hair samples were allowed to dry for at least 12 hours, washed, and then 
analyzed. 
5.1.5 Measurement of Cortisol in Saliva and Sweat 
 Sweat and saliva samples were analyzed as per the commercially 
available salivary ELISA from Alpco Diagnostics (Salem, NH, USA).  The intra-
assay and inter-day coefficients of variation were determined to be 10.31% and 
4.13%, respectively.  The kit reported a sensitivity of 1.0ng/ml. 
5.1.6 Hair Cortisol Analysis 
 Hair cortisol analysis was performed in accordance with a protocol our 
laboratory has established (Sauvé et al. 2007, Thomson et al. 2008).  Briefly, 10-
15 mg of each hair sample was placed in a scintillation vial, 1 ml of methanol was 
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added, and the hair segments were minced with surgical scissors until the hair 
became granular in appearance.  The vials were sealed and incubated at 50oC 
for 16 hours at 0.28 g.  The methanol solution containing cortisol extracted from 
the hair was then pipetted into a 5 ml test tube, placed on a hot plate at 50oC and 
evaporated under a stream of nitrogen gas.  The remaining residue was then 
reconstituted with 250 µl of phosphate buffered saline.  These reconstituted 
samples were analyzed as per the commercially available salivary enzyme linked 
immunoassay kit from Alpco Diagnostics (Salem, NH, USA).  The kit reported a 
sensitivity of 1.0ng/ml. 
5.1.7 Statistical Analysis 
Results are presented as mean±SD unless indicated otherwise. Data was 
assessed for normality using Kolmogorov-Smirnov test; non-normally distributed 
data was log-transformed before statistical analysis.  Correlation coefficients 
between different parameters were calculated with Pearson’s correlation 
coefficient for normally distributed data,.   A repeated measures ANOVA with a 
post-hoc Bonferroni test was used to examine if differences existed among the 
control and treatment conditions for the hydrocortisone immersion experiments.  
GraphPad Prism version 4.0b was used for all statistical analyses (GraphPad 
Software Inc. La Jolla, CA, USA), a p value below 0.05 was considered 
statistically significant. 
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5.2 Hair Cortisol Concentrations in Patients with Obstructive Sleep Apnea 
5.2.1 Ethical considerations   
The study protocol was approved by the University of Western Ontario 
Health Sciences Research Ethics Board (REB #17340E).  Each subject gave 
written informed consent prior to enrolment. 
5.2.2 Subjects 
The subjects recruited were patients who had been referred to the Sleep 
Clinic at South Street Hospital (London, Ontario) to investigate possible OSA, but 
had not yet been placed on CPAP.  Subjects could be included if they were 18 
years of age or older, and had undergone a polysomnogram within the last 4 
months.  Subjects were excluded if they indicated a medical history that is known 
to affect HPA axis functioning.  This included the use of oral or parenteral 
glucocorticoids in the past 3 months, the use of topical glucocorticoids in the past 
1-month, diagnosis with Cushing Syndrome, heart or renal failure, and 
pregnancy.  Additionally, any subject unwilling or unable to provide a 2cm sample 
of hair was excluded. 
Subjects were informed that if they elected to be placed on CPAP, a 
second assessment would be done at their 3-month follow-up appointment if they 
consented.  For the follow-up visit the same exclusion criteria applied. 
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5.2.3 Physical Exam Characteristics and Medical History 
Consult visit:  
For each subject we recorded the age, sex, height and weight (to calculate 
BMI), neck circumference, blood pressure, and heart rate.  Additionally, daily 
alcohol consumption, smoking status, and “pack years” (number cigarette packs 
smoked per day multiplied by the number of years smoking) were recorded from 
each subject, as both alcohol consumption and smoking are known to alter HPA 
axis activity. 
Past medical history information was gathered from each subject’s 
hospital chart.  The current and past diagnoses were noted, as well as the 
surgical history.  All of the current medications and dosages were recorded for 
each subject. 
Follow-up visit:   
We recorded weight and blood pressure, and any changes to alcohol 
consumption, smoking status, current diagnoses, and medication use.  Finally, 
we inquired about any major psychosocial stressors such as a death in the 
family, loss of employment, and others. 
5.2.4 Sleep Information Recorded 
Consult visit:  The most recent polysomnogram information was obtained for 
each subject.  The polysomnogram had to be obtained within the past 4 months 
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to be considered a close representation of the subject’s current status.  The 
number of arousals from sleep per hour, total sleep time, and AHI were obtained.  
The time spent in NREM and REM sleep, and the percentage of time spent 
below a 90% oxygen saturation for both NREM and REM sleep was also 
recorded.  This allowed for a calculation of the total time spent in a hypoxemic 
state during the polysomnogram.  Additionally, the ESS score from the day of the 
sleep study was obtained. 
Follow-up visit: 
 A subjective assessment of how well CPAP was working was obtained 
from each subject.  Additionally, each subject’s reported use of his/her CPAP 
machine was noted.  This included the number of nights per week, and the 
number of hours per night.  For subjects that had brought their CPAP machines 
with them, sleep information was downloaded off of the machine’s memory card, 
if capable.  This information included the subject’s compliance, as measured by 
the percentage of days used for longer than 4 hours, the average or median daily 
usage, and the AHI while using CPAP. 
5.2.5 Stress Measurements 
Consult visit: A hair sample of approximately 4-5 millimeters in diameter was 
obtained from the base of the hair shaft at the vertex posterior of each subject as 
per our standard protocol.  The sample was cut with surgical scissors and 
secured on a hair collection page with non-tack tape.  An arrow was used to 
indicate the scalp end of the hair.  This hair sample was stored in an envelope at 
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room temperature until analysis for hair cortisol.  The surgical scissors were 
cleaned with isopropanol between subjects as a means of preventing cross-
contamination. 
 Each subject was asked to complete the PSS, a validated questionnaire 
assessing perceived stress over the last 1 month of his/her life.  The PSS scores 
were tallied upon completion. 
Follow-up visit: A second hair sample and a second PSS were obtained in the 
same manner as the consult visit.   
5.2.6 Hair Cortisol Analysis 
 The hair samples were removed from the hair collection page and 
sectioned using a utility knife.  The most proximal 2 centimeters of hair, 
representing the most recent 2 months of cortisol secretion were cut.  The 
segments were placed in a 5 ml scintillation vial, weighed and 10-15 mg of hair 
was used.  The segments were then washed.  The wash consisted of a 3 ml of 
isopropanol immersion, incubation at room temperature, shaking at 100 RPM for 
3 minutes, followed by decanting.  This process was repeated once, and then the 
hair samples were dried for at least 5 hours in a fume hood. 
The remainder of hair cortisol analysis was performed in accordance with 
a protocol our laboratory has established (Sauvé et al. 2007, Thomson et al. 
2008).  Briefly, 1 ml of methanol was added to the scintillation vial, and the hair 
segments were minced with surgical scissors until the hair became granular in 
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appearance.  The vials were sealed and incubated at 50oC for 16 hours, rotating 
at 100 RPM.  The methanol solution containing cortisol extracted from the hair 
was then pipetted into a 5 ml test tube, placed on a hot plate at 50oC and 
evaporated under a stream of nitrogen gas.  The remaining residue was then 
reconstituted with 250 µl of PBS.  These reconstituted samples were analyzed as 
per the commercially available salivary enzyme linked immunoassay kit from 
Alpco Diagnostics (Salem, NH, USA).  The kit reported a sensitivity of 1.0ng/ml.  
In accordance with past studies, hair cortisol concentrations in excess of 1,500 
ng/g were excluded on the basis of possible glucocorticoid contamination 
(Thomson et al., 2009). 
5.2.7 Statistical Analysis 
Results are presented as mean±SD unless indicated otherwise. Analysis 
of data obtained from the consult visit was performed by comparing the hair 
cortisol concentrations of each subject with the various parameters obtained from 
the polysomnogram.  Both linear and nonlinear regressions were used to try to 
model hair cortisol concentrations with AHI, ESS, arousals per hour, and total 
hypoxemic time.  The hair cortisol concentrations of patients with mild, moderate, 
and severe OSA were compared using a 1-way ANOVA with post-hoc Bonferroni 
tests.  Pair two-tailed t-tests were used to compare the AHI and PSS scores of 
subjects below and after placement on CPAP.  GraphPad Prism version 4.0b 
was used for all statistical analyses (GraphPad Software Inc. La Jolla, CA, USA); 
a p value at or below 0.05 was considered statistically significant. 
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Chapter 6: Results   
6.1 The Detection of Cortisol in Human Sweat—Implications for Measurement of 
Cortisol in Hair 
We recruited 17 subjects; their characteristics are displayed in Table 2. 
Subjects included varsity rowers, recreational soccer players, and recreational 
long distance runners, and had done intensive exercise making them sweat 
profusely for at least 10 minutes.   
Table 2: Athlete characteristics* 
Age 25±9.3 (19-58) 
Gender (M:F) 12 (71%) : 5 (29%) 
BMI  24.2±2.94 
Smokers  0 
Alcohol drinks per day (median [range]) 0 [0-3] 
Subjects taking prescription drugs 0 
Time of sampling (median [range]) 10:40h [07:40-22:00h] 
*Results are presented as mean±SD unless indicated otherwise 
Sweat cortisol concentrations were 74.62±41.51ng/ml (mean±SD), 
ranging from 8.16-141.7ng/ml.  The concentration of sweat cortisol determined 
was dependent on the time of day collected, with the highest concentrations 
being found in morning samples and lower concentrations in evening samples.  
 Sweat cortisol concentrations were significantly correlated with the log 
transformed time of day (r=0.66, 
were significantly correlated with salivary cortisol concentrati
(Fig. 3). 
Figure 2: The association between sweat cortisol concentrations and the time of 
day (r=0.66, p<0.01); n=17
values were log corrected.
 
p<0.01)(Fig. 2).  Sweat cortisol concentrations 
ons (r=0.55, 
 
.  When analyzing with linear regression, time of day 
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p<0.05) 
 Figure 3: The association between sweat cortisol concentrations and salivary 
cortisol concentrations (r=0.55, 
 Twelve and 24-hour hair exposure to the cortisol containing solution 
resulted in increased hair cortisol content (
identified that the control group had a significantly lower hair cortisol 
concentration (p<0.001) when compared to all of the treatment conditions, but 
none of the treatment conditions differed significantly from each other.  Longer 
incubation periods were shown to significantly increase hair cortisol content 
(p<0.001).  Post-hoc analysis identified that hair cortisol concentrations for hair 
samples that had incubated for 60 and 120 minutes were significantly increased 
from the control concentr
samples incubated for 120 minutes had significantly increased cortisol relative to 
those that had only incubated for 15 an
 
 
p<0.05); n=17. 
p<0.001) (Fig. 4). Post-
ation (p<0.01 and p<0.001, respectively).  Further, hair 
d 30 minutes (p<0.001) (Fig. 5
58 
hoc analysis 
). 
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Figure 4: Effect of prolonged hair immersion for 12 or 24 hours in a 50ng/ml 
hydrocortisone PBS solution (mimicking sweat containing cortisol) and washing 
on hair cortisol concentrations. W: pre-analysis wash; * p<0.001 compared to 
control; n=14.  Data displayed as mean±SD. 
 
Figure 5: Effect of immersion time on hair cortisol concentrations. Hair samples 
were immersed a 50ng/ml hydrocortisone PBS solution for 15-120 minutes, 
followed by an isopropanol wash; n=7.  Data displayed as mean±SD. 
* p<0.01, **p<0.001 for hair cortisol compared to control.   
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6.2 Hair Cortisol Concentrations in Patients with Obstructive Sleep Apnea 
6.2.1 Results from Consult Visit 
Ninety-three subjects were recruited; their characteristics are displayed in 
Table 3.  Of the subjects recruited, two were excluded, one of the basis of 
prednisone use, and another because an insufficient amount of hair was 
obtained.   
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Table 3: Obstructive sleep apnea patient physical exam characteristics and 
medical history (n=91)* 
Age 55±11 years 
Gender (M:F) 56 (61%) : 35 (39%) 
BMI  35.4±7.3 kg/m2 
Mean Arterial Pressure  98±10 mmHg 
Neck circumference 42.9±5.1 cm 
Smokers  14 (15%) 
Alcohol drinks per day (median [range]) 0 [0-3.5] 
Subjects taking prescription drugs 78 (86%) 
Comorbidities 
 Hypertension 
 Hyperlipidemia 
 Type II Diabetes 
 Past Myocardial Infarction 
 Chronic Obstructive Pulmonary Disease 
 Hypothyroidism 
 Gastroesophageal Reflux Disease 
 Arthritis 
 Fibromyalgia 
 Depression 
 Anxiety 
 
45 (49%) 
23 (25%)  
14 (15%) 
7 (8%) 
5 (5%) 
6 (7%) 
9 (10%) 
5 (5%) 
7 (8%) 
14 (15%) 
8 (9%) 
*Results are presented as mean±SD unless indicated otherwise 
62 
 
 The sleep parameters collected at the time of each subject’s initial 
polyosomnogram are displayed in Table 4.  The mean PSS score was 17±7.9.  
The median hair cortisol concentration was 191.1 ng/g (range 66.2—1152 ng/g).   
Table 4: Summary of the obstructive sleep apnea patient physical exam 
characteristics and medical history (n=91)* 
Total sleep time 332.2±62.3 min 
NREM time 278.3±50.5 min 
REM time (median [range]) 52 [0—153] min 
Total hypoxemic time (median [range]) 12.1 [0—260] min 
Arousals/h (median [range]) 27.2 [4.6—98.4] 
AHI (median [range]) 31.0 [8.1—147.2] 
OSA Severity 
 Mild 
 Moderate 
 Severe 
 
15 (17%) 
24 (28%) 
47 (55%) 
ESS Score (median [range]) 10 [1—23] 
*Results are presented as mean±SD unless indicated otherwise 
 When examining how the parameters taken during the polysomnogram 
correlated with hair cortisol concentrations, the following relationships were 
observed.  AHI did not have a significant linear or nonlinear association with hair 
cortisol concentrations (Fig. 6).  A one-way ANOVA comparison OSA severity 
subgroups with hair cortisol concentrations was also not significant (p=0.31) (Fig. 
7).  However, the grouped hair cortisol concentrations of moderate and severe 
OSA patients were almost significantly increased (p=0.056) when compared to 
 mild OSA patients (one
was significantly associated with hair cortisol concentrations (r
when an exponential decay model was applied (Fig. 9).  A trend (
towards a positive linear correlation between arousals per hour and hair cortisol 
concentrations was noted (Fig. 10).  Finally, no significant associations were 
observed when comparing PSS or
Figure 6: Hair cortisol concentrations with respect to AHI; n=80
as mean±SD. 
 
 
-tailed Mann Whitney test) (Fig. 8).  Total hypoxemic time 
2
=0.063; 
p
 ESS scores with hair cortisol concentrations.
 
. Data displayed 
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p<0.05) 
=0.1010) 
 
 Figure 7: Hair cortisol concentrations in patients with mild, moderate and severe 
OSA (p=0.31); n=80.  Data 
Figure 8: Hair cortisol concentrations of grouped moderate and severe OSA 
patients trend towards being significantly higher than mild OSA patients 
(p=0.056); n=80.  Data displayed as mean±SD.
 
displayed as mean±SD. 
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 Figure 9: Total hypoxemic
compared with hair cortisol concentrations (r
Figure 10: The number of arousals per hour trends towards a weak significant 
positive linear correlation with hair cortisol concentrations (r
n=80.  
6.2.2 Results from Intervention
 Second hair samples and PSS were collected from 31 of the patients who 
returned to the sleep clinic after 3 months of CPAP.  A two
 
 time follows an exponential decay pattern when 
2
=0.063; p<0.05); n=80
 
2
=0.036; 
 
-tailed Wilcoxon 
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. 
p=0.1010); 
 matched pairs test did not detect a significant difference
concentrations after placement on CPAP (
t-test detected a significant decrease in perceived stress following placement on 
CPAP (p<0.001) (Fig. 12).
Figure 11: No significant differences are 
before and after placement on CPAP (
mean±SD. 
 
 in hair cortisol 
p=0.69) (Fig. 11).  A paired two
 
 
observed in hair cortisol concentrations 
p=0.69); n=31.  Data displayed as 
66 
-tailed 
 Figure 12: Levels of perceived stress are significantly reduced following a 3 
month placement on CPAP (
 Of the 31 patients who returned for a follow
only 21 had either remembered to bring their CPAP machine to the appointment 
or had a machine capable of downloading sleep information off of it.  A sub
analysis of these patients was performed, examining their pre
AHI scores, hair cortisol concentrations, and PSS scores.  
CPAP use was 5 hours and 49 minutes per night.  
matched pairs test revealed that the AH
significantly reduced when placed on CPAP (
entire group of follow-up patients, hair cortisol concentrations were not 
significantly changed (p
reduced (p<0.001) (Fig. 15).  Additionally, when comparing the change in 
perceived stress with the change in AHI, a significant positive linear association 
was found (p=0.0164) (Fig. 16).  No significant correlations were found when 
 
p<0.001); n=31.  Data displayed as mean±SD.
-up appointment after CPAP, 
- and post
The mean duration of 
A one-tailed Wilcoxon 
I scores of these patients were 
p<0.0001) (Fig. 13).  Similar to the 
=0.78)(Fig. 14) and perceived stress was significantly 
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-group 
-CPAP 
 comparing either the change in AHI with the change in hair cortisol 
concentrations, or the change in perceived stress with the change in hair cortisol 
concentrations. 
Figure 13: Patient AHI values are significantly reduced after placement on CPAP 
(p<0.0001); n=21.  Data displayed as mean±SD.
Figure 14: Subgroup analysis of patients who had a follow
cortisol concentrations are not significantly different after placement on CPAP 
(p=0.78); n=21.  Data displayed as mean±SD.
 
 
                     
-up AHI value.  Hair 
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 Figure 15: Subgroup analysis of patients who had a follow
of perceived stress are significantly reduced after placement on CPAP 
(p=0.0009); n=21.  Data displayed as mean±SD.
Figure 16: The change in AHI is significantly positively c
change in perceived stress (
 
 
 
-up AHI value.  Levels 
 
 
orrelated with the 
p=0.0164); n=21. 
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Chapter 7: Discussion 
7.1 The Detection of Cortisol in Human Sweat—Implications for Measurement of 
Cortisol in Hair 
 To our knowledge this is the first report to date that has employed an 
ELISA to detect cortisol in sweat.  The presence of a quantifiable amount of 
cortisol in sweat lends support to the proposal that some of the hair cortisol 
content in hair is of eccrine origin.  Similar to salivary cortisol concentrations, 
which are known to represent the free, unbound fraction of cortisol in the blood 
(Jessop & Turner-Cobb, 2008), it is plausible that sweat cortisol concentrations 
also represent the free fraction of hormone.  Further, the correlation suggests 
that cortisol in sweat, like in saliva reflects acute HPA activity (Kudielka et al. 
2008). 
 The hydrocortisone immersion experiments underscore the need to record 
personal hygiene habits (e.g. how recently a subject has washed his/her hair, 
how frequently and for how long the subject sweat extensively) when conducting 
studies that use hair cortisol analysis.  The results demonstrate that when hair is 
exposed to sweat cortisol concentrations well within the range of concentrations 
that were observed clinically hair cortisol content is substantially increased 
(p<0.001).  This increase does not appear to be dependent on the duration of 
exposure at durations of longer than 12 hours.  Importantly, the standard wash 
procedure used to remove external contaminants proved ineffective in removing 
the cortisol from the hair that was added from the hydrocortisone solution.  Thus, 
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if hair samples were collected from subjects in whom hair hygiene varied 
significantly, washing would likely fail to normalize the concentrations and 
present a significant confounder.  These results contrast a study by Hamel et al. 
(2011) in which repeatedly exposing hair samples to shampoo washes 
decreased the hair cortisol concentrations.  A possible reason for this contrast is 
that surfactants are potentially more effective than alcohol washes at removing 
sweat and sebum from hair. 
 When hair is exposed to hydrocortisone for shorter periods of time, more 
in line with real-life duration of exposure of hair to sweat, relationship between 
exposure time and hair cortisol content becomes more apparent.  When exposed 
to hydrocortisone for just 60 minutes, the hair cortisol concentrations are 
significantly increased from a brief control exposure (p<0.01).  Thus, if hair 
samples were collected when a subject had been sweating for 60 minutes, it is 
possible the hair cortisol concentration determined would be increased than if the 
individual was not sweating.  A previous paper found increased hair cortisol 
concentrations in athletes compared to control subjects. In light of the current 
findings it is conceivable that some of this increase in hair cortisol content may 
be due to prolonged sweating (Skoluda et al., 2011). 
 A limitation to this study was that only perspiration induced through 
intensive exercise was examined.  Cortisol concentrations are known to increase 
during periods of physical stress such as exercise (Shojaei et al. 2011), therefore 
it is possible that the sweat cortisol levels were temporarily elevated in our 
treatment conditions.  However, increased cortisol concentrations have been 
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noted in cases of passive hyperthermia (Jimenez et al., 2007).  Further, in 
conditions such as acute myocardial infarctions or fever, where diaphoresis is a 
common symptom, elevated cortisol concentrations are noted as well (Vallance 
et al., 1978).  Thus, most conditions that induce sweating are likely to be 
associated with elevated cortisol concentrations.   
Recently, 11B-HSD 1 has been shown to be expressed in the skin 
(Tiganescu et al. 2011).  This expression was significantly correlated with age 
and with photo-exposure.  This finding suggests that cortisol may be produced in 
excess at the level of the dermis and epidermis.  Therefore, sweat cortisol 
concentrations may be proportionally higher than what could be expected 
systemically.   While this may be true of sweat, it does not likely translate to a 
proportionally higher hair cortisol concentration as past studies have 
demonstrated that changes hair cortisol concentrations closely mirror the 
changes in serum cortisol concentration in patients receiving a successful 
intervention for Cushing Syndrome (Thomson et al., 2009). 
Additionally, it would have been preferable to examine any inter-day 
variations in sweat cortisol concentrations to try to establish its stability over time.  
Another limitation to this study is that multiple sweat collections were not 
performed on the same individual at multiple time points.  This design would 
have being capable of more robustly demonstrating if a diurnal variation occurs 
for sweat cortisol concentrations.  Future studies should also examine in vivo 
cases of sweating and observe if similar increases in hair cortisol concentrations 
are observed. 
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In previous studies both our group and others have shown that the 
patterns of change in hair cortisol, when segmented to reflect month-by-month 
exposure, closely follow the changes measure in blood and saliva.  This was 
commonly interpreted that most of the hair load of cortisol enters the shaft from 
the blood.  Our new observation, that sweat contains cortisol in levels reflecting 
systemic concentrations, and that sweat cortisol is not easily washable from the 
hair shaft, indicate that at least some of the measured cortisol in hair may stem 
from sweat.  Because sweat cortisol significantly correlates with systemic levels 
of the hormone, sweat-derived cortisol is not likely to disrupt the correlation 
between hair cortisol and blood. 
7.2 Hair Cortisol Concentrations in Patients with Obstructive Sleep Apnea 
 Initially the apparent downregulation of HPA activity, as shown by hair 
cortisol concentrations, in response to an increased AHI or increased total 
hypoxemic time is somewhat paradoxical.  In both in vitro and in vivo models, a 
hypoxemic environment has been demonstrated to down regulate the expression 
of 11β-HSD2 (Heiniger et al., 2003).  In this event, cortisol excretion in the form 
of cortisone is reduced, and an increase in circulating cortisol would be expected. 
 Not all studies have linked a hypoxic environment with an increase in 
cortisol.  A recent study that used healthy volunteers compared the effects of 5 
hours of intermittent hypoxia on serum cortisol, but failed to detect any change in 
serum cortisol concentrations (Louis & Punjabi, 2009).  In a study of 14 healthy 
men subjected to a hypoxic condition that reduced their oxygen saturation to 
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75%, their serum cortisol was not significantly different from the normoxic control 
condition (Oltmanns et al., 2004).  Likewise, Benso et al. (2007) studied 9 
mountaineers at sea level and at 5,200m after summiting Mt Everest 7 weeks 
later, and the chronically hypoxic environment did not significantly affect serum 
cortisol concentrations. 
 HPA downregulation is also observed in a number of other clinical 
examples of severe chronic stress.  The hallmark example is PTSD.  As 
mentioned earlier, cortisol is thought to be initially increased in the case of PTSD, 
but as the stressor becomes less salient and the duration from the initial stressor 
becomes more temporally distant, cortisol secretion has been shown to decline 
below normal levels—suggesting negative feedback overregulation.  In addition 
to PTSD, chronic pain (Gaab et al., 2005), rheumatoid arthritis and asthma (Heim 
et al., 1999; Riedel et al., 2002) have been associated with hypocortisolism.  
Finally, recently hair cortisol analysis has been used to indentify HPA 
downregulation in cases of temporomandibular joint disorder and in boys that 
were born pre-term (unpublished findings). 
 In the follow-up patient sample, in spite of significant clinical improvement, 
the hair cortisol changes were not significantly different.  When interpreting the 
effect that CPAP had on hair cortisol concentrations, the number of patients with 
comorbid conditions known to be associated with increased cortisol secretion.  
Hypertension (Martins et al., 2012), type II diabetes,  (Reynolds et al., 2010), and 
depression (Zunszain et al., 2011) were all common comorbidities of patients in 
this study, and their association with hypercortisolemia may have masked any 
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change that CPAP had on cortisol secretion.  Additionally, the noted reduction in 
perceived stress may suggest that psychological stress is more rapidly 
responsive to clinical improvement, whereas physiological changes in stress may 
require a longer duration before improvement is observed.  However, a limitation 
to this study is that the participants were not blinded to the research question of if 
hair cortisol and physiologic stress are altered by being placed on CPAP.  
Therefore, they may have been biased, whether consciously or subconsciously, 
to report reduced psychological stress at the follow-up appointment. 
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Chapter 8: Conclusions 
It is conceivable that hair cortisol analysis will continue to be adopted as a 
useful tool for measuring chronic stress in many clinical and experimental 
situations.  Currently it is not available in most laboratories, even though the 
methodology and technology are relatively simple and straightforward, thus 
allowing a seamless integration with existing biomonitoring techniques.  
Developing a complete knowledge of how sweat and sebum contribute to total 
hair cortisol content will be useful when interpreting results.  As observed in this 
project, sweat cortisol may significantly increase hair cortisol content even when 
attempts are made to normalize it with the use of isopropanol washes.  
Additionally, hair cortisol analysis is continuing to provide new insight of how 
HPA functioning is altered in disease states.  Specifically, hair cortisol analysis 
may help discern the complex changes cortisol secretion, such as in the case of 
OSA. 
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Appendix C: Perceived Stress Scale 
Perceived Stress Scale 
 
The questions in this scale ask you about your thoughts and feelings during the last month. 
In each case, you will be asked to indicate by circling how often you felt or thought a certain 
way.  
Participant Code:_____________ Date:_________________________  
Age:____________ 
Gender (circle) M   F  
 
0= Never 1= Almost Never 2= Sometimes 3= Fairly Often 4= Very Often 
 
1. In the last month, how often have you been upset 
because of something that happened unexpectedly?  
0    1    2    3    4  
2. In the last month, how often have you felt that you were 
unable to control the important things in your life?  
0    1    2    3    4  
3. In the last month, how often have you felt nervous or, 
“stressed?”  
0    1    2    3    4  
4. In the last month, how often have you felt confident 
about your ability to handle your personal problems?  
0    1    2    3    4  
5. In the last month, how often have you felt that things 
were going your way?  
0    1    2    3    4  
6. In the last month, how often have you found that you 
could not cope with all the things that you had to do?  
0    1    2    3    4  
7. In the last month, how often have you been able to 
control irritations in your life?  
0    1    2    3    4  
8. In the last month, how often have you felt that you were 
on top of things?  
0    1    2    3    4  
9. In the last month, how often have you been angered 
because of things that were outside of your control?  
0    1    2    3    4  
10. In the last month, how often have you felt that 
difficulties were pilling up so high that you could not overcome 
them?  
0    1    2    3    4  
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Appendix D: Epworth Sleepiness Scale 
 
Directions: How likely are you to doze off or fall asleep in the following situations, 
in contrast to feeling just tired.  This refers to your usual way of life in recent 
times.  Even if you have not done some of these things recently, try to work out 
how they would have affected you.  Use the following scale to rate your chance 
of dozing in each situation.  Circle the correct number to indicate your chance of 
dosing for each item below. 
 
0= would never doze 
1= slight chance of dozing 
2= moderate chance of dozing 
3= high chance of dozing 
 
1. Sitting and reading 0    1    2    3     
2. Watching TV 0    1    2    3     
3. Sitting, inactive in a public place (e.g., a theatre or a 
meeting) 
0    1    2    3      
4. As a passenger in a car for an hour without a break  0    1    2    3      
5. Lying down to rest in the afternoon when circumstances 
permit  
0    1    2    3      
6. Sitting and talking to someone  0    1    2    3     
7. Sitting quietly after a lunch without alcohol  0    1    2    3      
8. In a car, while stopped for a few minutes in the traffic  0    1    2    3      
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Appendix E: Information collection page for sweat study 
Information Collection Page—Sweat Study 
Participant Code: ____________ Sex: ______________      
Date:      Time: _________________ 
Pre-collection checklist: 
o Taking any oral, parenteral glucocorticoids in past 3 months? (Y/N; if yes, please 
provide the name of the medication) 
 
 
o Used any hydrocortisone containing creams in past month? 
 
 
o Currently pregnant? (Y/N/unsure) 
 
 
o Height: ______________     Weight: ______________ 
 
 
o Smoking Status (Y/N; if yes, how many years of smoking, and how many 
packs/day?): 
 
 
o Alcohol consumption (standard alcoholic drinks/day): _____________________     
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Appendix F: Information collection page for OSA study 
Checklist for Participants at the Sleep Clinic 
Participant Code:      
 Letter of information and consent read and signed. 
 Participant has a signed copy of the letter of information and consent. 
 Participants are familiar with exclusion criteria: 
• Oral, parenteral glucocorticoids in past 3 months 
• Cushing’s Syndrome 
• Use of hydocortisone-containing creams in past month 
• Major systemic disease 
• Pregnancy 
• Unwilling/Unable to donate 2cm sample 
 Perceived Stress Scale has been completed by the participant. 
 Hair sample collected and place in envelope. 
 
 
Age: ________  Gender: __________ Height: _______ Weight: ________ 
Neck circumference: ________________ BP: _______  HR: ________ 
 
 
Current medical conditions: 
 
 
 
Current medications: 
 
Smoking 
Status: 
Alcohol 
Consumption: 
 
 
 
Apnea-Hypopnea Index 
(AHI):  
 
Epworth Sleepiness 
Scale (ESS):  
 
Arousals/h: 
 
 
 
NREM time: ___________% NREM time <90% O2 sat: _____________ 
 
 
 
REM time: _________ % REM time <90% O2 sat: _______________ 
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